InDex Pharmaceuticals Holding AB Financial Overview
InDex Pharmaceuticals Holding AB's market cap is currently €2.91B. The company's EPS TTM is kr-1.781; its P/E ratio is ―; InDex Pharmaceuticals Holding AB is scheduled to report earnings on October 22, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
